Is ImmuneOnco stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for ImmuneOnco 10 years ago, but if you had invested on Tuesday 5th of September 2023 when the price was HKD19.52, you would have made a loss of HKD-12.16 per share or -62.30%
Yes, the average daily trading liquidity for ImmuneOnco is HKD10.79 million. You should therefore be able to get in and out of your positions relatively fast.
ImmuneOnco has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for ImmuneOnco to be high [0.85 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.